Top

Published in:

01-04-1999

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

Authors: Massimo Cristofanilli, Frankie Ann Holmes, Laura Esparza, Vicente Valero, Aman U. Buzdar, James A. Neidhart, Gabriel N. Hortobagyi

Published in: Breast Cancer Research and Treatment | Issue 3/1999

Title: Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience
Authors: Massimo Cristofanilli
Frankie Ann Holmes
Laura Esparza
Vicente Valero
Aman U. Buzdar
James A. Neidhart
Gabriel N. Hortobagyi
Publication date: 01-04-1999
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 3/1999
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1006104610727

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/1999

The Fas/Fas‐ligand system: a mechanism for immune evasion in human breast carcinomas

Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost

Association between endometrial cancer and tamoxifen treatment of breast cancer

Coping with breast cancer: a cluster analytic approach

Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin

Incremental cost‐effectiveness of double‐reading mammograms

Keynote webinar | Spotlight on antibody–drug conjugates in cancer